Silk Road Medical Quarterly Income Statements Chart
Quarterly
|
Annual
Silk Road Medical Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenue | 51,242,000 | 48,484,000 | 47,270,000 | 44,435,000 | 45,298,000 | 40,131,000 | 40,071,000 | 37,374,000 | 33,173,000 | 28,021,000 | 28,265,000 | 24,701,000 | 26,456,000 | 22,053,000 | 21,134,000 | 20,067,000 | 15,094,000 | 18,933,000 | 18,633,000 | 17,026,000 | 14,928,000 | 12,766,000 |
| yoy | 13.12% | 20.81% | 17.97% | 18.89% | 36.55% | 43.22% | 41.77% | 51.31% | 25.39% | 27.06% | 33.74% | 23.09% | 75.27% | 16.48% | 13.42% | 17.86% | 1.11% | 48.31% | ||||
| qoq | 5.69% | 2.57% | 6.38% | -1.91% | 12.88% | 0.15% | 7.22% | 12.66% | 18.39% | -0.86% | 14.43% | -6.63% | 19.97% | 4.35% | 5.32% | 32.95% | -20.28% | 1.61% | 9.44% | 14.05% | 16.94% | |
| cost of goods sold | 12,736,000 | 11,983,000 | 12,468,000 | 12,050,000 | 13,004,000 | 12,526,000 | 10,979,000 | 9,308,000 | 9,012,000 | 8,577,000 | 7,233,000 | 6,076,000 | 6,598,000 | 5,538,000 | 5,217,000 | 5,488,000 | 5,336,000 | 5,250,000 | 4,721,000 | 4,170,000 | 3,697,000 | 3,339,000 |
| gross profit | 38,506,000 | 36,501,000 | 34,802,000 | 32,385,000 | 32,294,000 | 27,605,000 | 29,092,000 | 28,066,000 | 24,161,000 | 19,444,000 | 21,032,000 | 18,625,000 | 19,858,000 | 16,515,000 | 15,917,000 | 14,579,000 | 9,758,000 | 13,683,000 | 13,912,000 | 12,856,000 | 11,231,000 | 9,427,000 |
| yoy | 19.24% | 32.23% | 19.63% | 15.39% | 33.66% | 41.97% | 38.32% | 50.69% | 21.67% | 17.74% | 32.14% | 27.75% | 103.50% | 20.70% | 14.41% | 13.40% | -13.12% | 45.15% | ||||
| qoq | 5.49% | 4.88% | 7.46% | 0.28% | 16.99% | -5.11% | 3.66% | 16.16% | 24.26% | -7.55% | 12.92% | -6.21% | 20.24% | 3.76% | 9.18% | 49.41% | -28.69% | -1.65% | 8.21% | 14.47% | 19.14% | |
| gross margin % | 75.15% | 75.28% | 73.62% | 72.88% | 71.29% | 68.79% | 72.60% | 75.09% | 72.83% | 69.39% | 74.41% | 75.40% | 75.06% | 74.89% | 75.31% | 72.65% | 64.65% | 72.27% | 74.66% | 75.51% | 75.23% | 73.84% |
| operating expenses: | ||||||||||||||||||||||
| research and development | 11,883,000 | 10,660,000 | 10,064,000 | 10,047,000 | 10,780,000 | 10,433,000 | 9,200,000 | 8,471,000 | 10,655,000 | 8,123,000 | 7,499,000 | 6,867,000 | 7,261,000 | 5,484,000 | 10,039,000 | 4,711,000 | 3,393,000 | 3,131,000 | 3,264,000 | 3,187,000 | 3,113,000 | 2,707,000 |
| selling, general and administrative | 43,818,000 | 40,775,000 | 39,110,000 | 36,009,000 | 35,830,000 | 34,082,000 | 32,522,000 | 28,821,000 | 27,700,000 | 27,275,000 | 27,595,000 | 25,049,000 | 22,549,000 | 21,194,000 | 20,872,000 | 19,202,000 | 15,758,000 | 19,692,000 | 18,156,000 | 17,064,000 | 14,135,000 | 13,866,000 |
| total operating expenses | 55,701,000 | 51,435,000 | 49,174,000 | 46,056,000 | 46,610,000 | 44,515,000 | 41,722,000 | 37,292,000 | 38,355,000 | 35,398,000 | 35,094,000 | 31,916,000 | 29,810,000 | 26,678,000 | 30,911,000 | 23,913,000 | 19,151,000 | 22,823,000 | 21,420,000 | 20,251,000 | 17,248,000 | 16,573,000 |
| income from operations | -17,195,000 | -14,934,000 | -14,372,000 | -13,671,000 | -14,316,000 | -16,910,000 | -12,630,000 | -9,226,000 | -14,194,000 | -15,954,000 | -14,062,000 | -13,291,000 | -9,952,000 | -10,163,000 | -14,994,000 | -9,334,000 | -9,393,000 | -9,140,000 | -7,508,000 | -7,395,000 | -6,017,000 | -7,146,000 |
| yoy | 20.11% | -11.69% | 13.79% | 48.18% | 0.86% | 5.99% | -10.18% | -30.58% | 42.62% | 56.98% | -6.22% | 42.39% | 5.95% | 11.19% | 99.71% | 26.22% | 56.11% | 27.90% | ||||
| qoq | 15.14% | 3.91% | 5.13% | -4.51% | -15.34% | 33.89% | 36.90% | -35.00% | -11.03% | 13.45% | 5.80% | 33.55% | -2.08% | -32.22% | 60.64% | -0.63% | 2.77% | 21.74% | 1.53% | 22.90% | -15.80% | |
| operating margin % | -33.56% | -30.80% | -30.40% | -30.77% | -31.60% | -42.14% | -31.52% | -24.69% | -42.79% | -56.94% | -49.75% | -53.81% | -37.62% | -46.08% | -70.95% | -46.51% | -62.23% | -48.28% | -40.29% | -43.43% | -40.31% | -55.98% |
| interest income | 2,321,000 | 2,471,000 | 2,618,000 | 2,617,000 | 2,434,000 | 2,287,000 | 1,776,000 | 617,000 | 122,000 | 12,000 | 15,000 | 42,000 | 47,000 | 95,000 | 153,000 | 249,000 | 299,000 | 404,000 | 441,000 | 565,000 | 598,000 | 52,000 |
| interest expense | -1,725,000 | -1,721,000 | -1,734,000 | -1,732,000 | -1,712,000 | -1,693,000 | -1,732,000 | -1,714,000 | -1,031,000 | -621,000 | -634,000 | -633,000 | -628,000 | -623,000 | -791,000 | -1,215,000 | -1,203,000 | -1,202,000 | -1,216,000 | -1,176,000 | -1,207,000 | -1,352,000 |
| other income | -4,000 | 48,000 | 477,000 | -2,000 | 110,000 | -144,000 | -28,000 | 4,000 | -50,000 | -116,000 | -12,000 | -3,000 | -6,000 | -3,000 | -6,000 | -15,000 | -56,000 | -3,000 | -8,000 | -1,000 | -5,333,000 | -15,712,000 |
| net income | -16,603,000 | -14,136,000 | -13,011,000 | -12,788,000 | -13,484,000 | -16,460,000 | -12,614,000 | -10,319,000 | -15,398,000 | -16,679,000 | -14,693,000 | -13,885,000 | -10,539,000 | -10,694,000 | -16,757,000 | -10,315,000 | -10,353,000 | -9,941,000 | ||||
| yoy | 23.13% | -14.12% | 3.15% | 23.93% | -12.43% | -1.31% | -14.15% | -25.68% | 46.10% | 55.97% | -12.32% | 34.61% | 1.80% | 7.57% | ||||||||
| qoq | 17.45% | 8.65% | 1.74% | -5.16% | -18.08% | 30.49% | 22.24% | -32.98% | -7.68% | 13.52% | 5.82% | 31.75% | -1.45% | -36.18% | 62.45% | -0.37% | 4.14% | |||||
| net income margin % | -32.40% | -29.16% | -27.52% | -28.78% | -29.77% | -41.02% | -31.48% | -27.61% | -46.42% | -59.52% | -51.98% | -56.21% | -39.84% | -48.49% | -79.29% | -51.40% | -68.59% | -52.51% | 0% | 0% | 0% | 0% |
| other comprehensive loss: | ||||||||||||||||||||||
| unrealized loss on investments | -105,000 | |||||||||||||||||||||
| other comprehensive income loss | -105,000 | |||||||||||||||||||||
| comprehensive loss | -16,708,000 | -14,225,000 | ||||||||||||||||||||
| net income per share | -0.42 | -0.36 | -0.34 | -0.33 | -0.35 | -0.43 | -0.33 | -0.29 | -0.44 | -0.48 | -0.42 | -0.4 | -0.31 | -0.31 | -0.5 | -0.31 | -0.32 | -0.32 | -0.1 | -0.26 | -0.42 | -20.12 |
| weighted-average common shares used to compute net income per share, basic and diluted | 39,620,888 | 39,261,496 | 38,804,343 | 38,865,011 | 38,765,166 | 38,532,202 | 35,775,672 | 35,303,958 | 35,143,178 | 35,023,297 | 34,635,358 | 34,736,015 | 34,534,099 | 34,336,433 | 33,757,599 | 32,682,360 | 31,338,310 | 30,764,354 | 28,458,793 | 1,200,719 | ||
| other comprehensive income: | ||||||||||||||||||||||
| unrealized gain on investments | -89,000 | 356,000 | 47,000 | -9,500 | -2,000 | -3,000 | -33,000 | -113,000 | -164,000 | -126,000 | ||||||||||||
| other comprehensive income | -89,000 | |||||||||||||||||||||
| loss on debt extinguishment | -245,000 | |||||||||||||||||||||
| other comprehensive loss | -29,500 | 47,000 | -414,000 | |||||||||||||||||||
| net income and comprehensive loss | -10,712,500 | -12,741,000 | -13,898,000 | -16,211,000 | -12,589,000 | -10,508,000 | -15,400,000 | -16,679,000 | -14,694,000 | -13,887,000 | -10,542,000 | -10,727,000 | -7,614,500 | -10,479,000 | -10,479,000 | -9,501,000 | -11,031,000 | -8,007,000 | -11,959,000 | -24,158,000 | ||
| change in unrealized loss on investments | -414,000 | |||||||||||||||||||||
| change in unrealized gain on investments | 249,000 | 25,000 | -189,000 | -2,000 | ||||||||||||||||||
| net change in other comprehensive loss | 249,000 | 25,000 | -189,000 | -2,000 | -1,000 | -2,000 | -3,000 | -33,000 | -113,000 | -164,000 | -126,000 | 440,000 | ||||||||||
| unrealized gains on investments | 440,000 | |||||||||||||||||||||
| net income and comprehensive loss attributable to non-controlling interest | ||||||||||||||||||||||
| net income and comprehensive loss attributable to silk road medical, inc. common stockholders | -8,289,000 | -8,007,000 |
We provide you with 20 years income statements for Silk Road Medical stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Silk Road Medical stock. Explore the full financial landscape of Silk Road Medical stock with our expertly curated income statements.
The information provided in this report about Silk Road Medical stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.